Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Chest

Volumn 132, Issue 3 SUPPL., 2007, Pages 306S-313S

  Arenberg, Douglas ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adenocarcinoma; Bronchioloalveolar; Cancer; Epidemiology; Guidelines; Therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION; ARTICLE; CLASSIFICATION; EVIDENCE BASED MEDICINE; LUNG TUMOR;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 34848878110     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1383     Document Type: Article

References (63)

1. Mallassez L. Histologic examination of a case of cancer of the lung (epithelioma). Arch Physiol Norn Pathol 1876; 3:353-372
2. Liebow AA. Bronchiolo-alveolar carcinoma. Adv Intern Med 1960; 10:329-358
3. Auerbach O, Garfinkel L. The changing pattern of lung carcinoma. Cancer 1991; 68:1973-1977
4. Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994; 73:1163-1170
5. Read WL, Page NC, Tierney RM, et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 2004; 45:137-142
6. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995; 75:2844-2852
7. Carretta A, Canneto B, Calori G, et al. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma. Eur J Cardiothorac Surg 2001; 20:367-371
8. Campione A, Ligabue T, Luzzi L, et al. Impact of size, histology, and gender on stage IA non-small cell lung cancer. Asian Cardiovasc Thorac Ann 2004; 12:149-153
9. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005; 23:3279-3287
10. Kim EA, Johkoh T, Lee KS, et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol 2001; 177:1417-1422
11. Volpino P, D'Andrea N, Cangemi R, et al. Bronchioloalveolar carcinoma: clinical, radiographic, and pathological findings; surgical results. J Cardiovasc Surg (Torino) 2001; 42:261-267
12. Charloux A, Hedelin G, Dietemann A, et al. Prognostic value of histology in patients with non-small cell lung cancer. Lung Cancer 1997; 17:123-134
13. Suzuki K, Nagai K, Yoshida J, et al. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer 1997; 79:1521-1526
14. Nakajima J, Furuse A, Oka T, et al. Excellent survival in a subgroup of patients with intrapulmonary metastasis of lung cancer. Ann Thorac Surg 1996; 61:158-162
15. Castro CY, Coffey DM, Medeiros LJ, et al. Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung. Ann Diagn Pathol 2001; 5:274-284
16. Volpino P, Cavallaro A, Cangemi R, et al. Comparative analysis of clinical features and prognostic factors in resected bronchioloalveolar carcinoma and adenocarcinoma of the lung. Anticancer Res 2003; 23:4959-4965
17. Tajiri M, Kameda Y, Nakayama H, et al. Prognosis and morphometrical features of non-bronchioloalveolar cell adenocarcinoma: an assessment of the non-alveolar replacing area and high grade atypical area. J Clin Pathol 2006; 59:269-273
18. Suzuki K, Asamura H, Kusumoto M, et al. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002; 74:1635-1639
19. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004; 28:198-206
20. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment. Ann Thorac Surg 2004; 78:1728-1733
21. Sakao Y, Sakuragi T, Natsuaki M, et al. Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung. Ann Thorac Surg 2003; 75:1113-1117
22. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg 2002; 74:1640-1647
23. Travis W, Colby T, Corrin B, et al. In collaboration with pathologists from 14 countries: World Health Organization international histological classification of lung and pleural tumours. 3rd ed. New York, NY: Springer-Verlag, 1999
24. Travis WD. Pathology of lung cancer. Clin Chest Med 2002; 23:65-81
25. Zell JA, Ou SHI, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 2005; 23:8396-8405
26. Zell JA, Ou SHI, Ziogas A, et al. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol 2006; 17:1255-1262
27. Barlesi F, Doddoli C, Gimenez C, et al. Bronchioloalveolar carcinoma: myths and realities in the surgical management. Eur J Cardiothorac Surg 2003; 24:159-164
28. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395-400
29. Yang ZG, Sone S, Takashima S, et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001; 176:1399-1407
30. Takashima S, Maruyama Y, Hasegawa M, et al. High-resolution CT features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components. Respiration 2003; 70:36-42
31. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001; 220:803-809
32. Garfield DH, Cadranel JL, Wislez M, et al. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. J Thorac Oncol 2006; 1:344-359
33. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. JAMA 2001; 285:914-924
34. Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998; 39:1016-1020
35. Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998; 170:935-939
36. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16:1075-1084
37. Heyneman LE, Edward F, Patz J. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 2002; 38:261-266
38. Marom EM, Sarvis S, Herndon JE II, et al. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002; 223:453-459
39. Lee KS, Jeong YJ, Han J, et al. T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. Radiographics 2004; 24:1617-1636
40. Jeong HJ, Min JJ, Park JM, et al. Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 2002; 23:865-870
41. Regnard JF, Santelmo N, Romdhani N, et al. Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors. Chest 1998; 114:45-50
42. Rena O, Papalia E, Ruffini E, et al. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg 2003; 23:409-414
43. Breathnach OS, Kwiatkowski DJ, Finkelstein DM, et al. Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg 2001; 121:42-47
44. Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg 2001; 71:971-974
45. Watanabe S, Watanabe T, Arai K, et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002; 73:1071-1075
46. Nakata M, Sawada S, Seiki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 2003; 75:1601-1605
47. Ishiwa N, Ogawa N, Shioji A, et al. Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas, in considering the indication of limited surgery. Lung Cancer 2003; 39:159-164
48. Koike T, Yamato Y, Yoshiya K, et al. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003; 125:924-928
49. Watanabe T, Okada A, Imakiire T, et al. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn J Thorac Cardiovasc Surg 2005; 53:29-35
50. Bell DW, Lynch TJ, Haserlat SM, et al. Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 2005; 23:8081-8092
51. Sorensen JB, Hirsch FR, Olsen J. The prognostic implication of histopathologic subtyping of pulmonary adenocarcinoma according to the classification of the World Health Organization: an analysis of 259 consecutive patients with advanced disease. Cancer 1988; 62:361-367
52. Breathnach OS, Ishibe N, Williams J, et al. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer 1999; 86:1165-1173
53. Pao W, Miller VA, Kris MG. 'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC). Semin Cancer Biol 2004; 14:33-40
54. Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2005; 2:e17
55. Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol 2003; 21:2237-2246 [published erratum appears in J Clin Oncol 2004; 22:4811]
56. Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 2003; 290:2149-2158
57. Dudek AZ, Kmak KL, Koopmeiners J, et al. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer. Lung Cancer 2006; 51:89-96
58. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004; 22:1103-1109
59. Lee DH, Han JY, Lee HG, et al. Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers. Clin Cancer Res 2005; 11:3032-3037
60. Argiris A, Mittal N. Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer. Lung Cancer 2004; 43:317-322
61. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353:123-132
62. Tsao MS, Sakurada A, Cutz JC, et al. Erlotinib in lung cancer: molecular and clinical predictors of outcome. N Engl J Med 2005; 353:133-144
63. Yamada S, Kohno T. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter. Ann Thorac Surg 2004; 77:1911-1915